Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) POC Lab Test Ecosystem Rollout Advances Fight Against COVID, Flu, RSV, Chronic Conditions

September 20, 2021

September 20, 2021 12:05:27
  • Health diagnostics technology innovator Avricore Health has introduced its HealthTab platform as a means of improving patients’ ability to monitor their health conditions through point-of-care testing under the guidance of trained pharmacists
  • HealthTab uses partnerships with molecular testing device makers to establish rapid molecular testing services in pharmacies, including the Shoppers Drug Mart pharmacy network in Ontario
  • The initial rollout has taken place in 15 Shoppers pharmacies, with rapid scaling planned to achieve more than 600 locations by the end of 2023
  • HealthTab’s diagnostics platform is designed to be high quality with appropriate approvals and certifications, helping patients to avoid delays in lab result turnaround
  • The COVID pandemic has exposed weaknesses in lab result turnaround time capacity, but Avricore’s testing offers solutions that include COVID infection analysis under a new agreement
The unexpected advent of the COVID-19 global pandemic last year taxed health response infrastructures on numerous fronts as the rapidly spreading SARS-COV-2 virus caused an influx of sick and dying patients at hospitals struggling to keep up with demands for intensive care. The health emergency exposed weaknesses in the diagnostic ecosystem, as well. Once testing protocols were developed, health experts still struggled to get labs the necessary resources and labs struggled to turn around test results in a timely fashion (https://ibn.fm/gdfiR). By November, many labs were reporting they had improved turnaround times for… Read More>> NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.